Effect of synbiotic supplementation on immune parameters and gut microbiota in healthy adults: a double-blind randomized controlled trial
Xiaoqin Li,Shan Hu,Jiawei Yin,Xiaobo Peng,Lei King,Linyan Li,Zihui Xu,Li Zhou,Zhao Peng,Xiaolei Ze,Xuguang Zhang,Qiangchuan Hou,Zhilei Shan,Liegang Liu
DOI: https://doi.org/10.1080/19490976.2023.2247025
IF: 12.2
2023-08-23
Gut Microbes
Abstract:Synbiotics are increasingly used by the general population to boost immunity. However, there is limited evidence concerning the immunomodulatory effects of synbiotics in healthy individuals. Therefore, we conducted a double-blind, randomized, placebo-controlled study in 106 healthy adults. Participants were randomly assigned to receive either synbiotics (containing <i>Bifidobacterium lactis</i> HN019 1.5 × 10<sup>8</sup> CFU/d, <i>Lactobacillus rhamnosus</i> HN001 7.5 × 10<sup>7</sup> CFU/d, and fructooligosaccharide 500 mg/d) or placebo for 8 weeks. Immune parameters and gut microbiota composition were measured at baseline, mid, and end of the study. Compared to the placebo group, participants receiving synbiotic supplementation exhibited greater reductions in plasma C-reactive protein (<i>P</i> = 0.088) and interferon-gamma (<i>P</i> = 0.008), along with larger increases in plasma interleukin (IL)-10 (<i>P</i> = 0.008) and stool secretory IgA (sIgA) (<i>P</i> = 0.014). Additionally, synbiotic supplementation led to an enrichment of beneficial bacteria (<i>Clostridium_sensu_stricto_1</i>, <i>Lactobacillus</i>, <i>Bifidobacterium</i>, and <i>Collinsella</i>) and several functional pathways related to amino acids and short-chain fatty acids biosynthesis, whereas reduced potential pro-inflammatory <i>Parabacteroides</i> compared to baseline. Importantly, alternations in anti-inflammatory markers (IL-10 and sIgA) were significantly correlated with microbial variations triggered by synbiotic supplementation. Stratification of participants into two enterotypes based on pre-treatment <i>Prevotella</i>-to-<i>Bacteroides</i> (<i>P</i>/<i>B</i>) ratio revealed a more favorable effect of synbiotic supplements in individuals with a higher <i>P</i>/<i>B</i> ratio. In conclusion, this study suggested the beneficial effects of synbiotic supplementation on immune parameters, which were correlated with synbiotics-induced microbial changes and modified by microbial enterotypes. These findings provided direct evidence supporting the personalized supplementation of synbiotics for immunomodulation.
gastroenterology & hepatology,microbiology